Press Releases

Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on October 15, 2026, it granted stock options to purchase shares of common stock to Stephen Aschettino, the Company’s newly-appointed Senior Vice President, Chief Information Officer, and seventeen other new employees, as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4). The company granted Mr. Asch

SINGAPORE, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd ("Trident" or the "Company") (NASDAQ:TDTH), a Singapore-headquartered digital infrastructure and technology holding company building sovereign-scale platforms across emerging markets, today announced its unaudited financial results for the six months ended June 30, 2026. First Half 2026 Financial Highlights Total revenues increased more than tenfold to US$384,741, compared to US$36,612 for the six months ended June 30, 2025.Gross profit increased more than twentyfold to US$356,879, compared to US$17,643 for the prior-year period.Gross margin expanded to approximately 93%, compared to approximately 48% for the

CHARLOTTE, N.C., Oct. 16, 2026 /PRNewswire/ -- Bank of America Corporation today announced the Board of Directors has authorized regular cash dividends on the outstanding shares or depositary shares of the following series of preferred stock:  Series of Preferred StockDividend per Share or Depositary Share1Record DatePayment DateFloating Rate Non-Cumulative Preferred Stock, Series E$0.27806October 30November 16Floating Rate Non-Cumulative Preferred Stock, Series F$1,151.69600November 30December 15Adjustable Rate Non-Cumulative Preferred Stock, Series G$1,151.69600November 30December 15Floating Rate Non-Cumulative Preferred Stoc

DALLAS, Oct. 16, 2026 /PRNewswire/ -- The NXG Cushing® Midstream Energy Fund (NYSE:SRV) (the "Fund") today announced that the Fund's Board of Trustees (the "Board") approved certain changes to the name of the Fund and the Fund's non-fundamental investment policies. Effective December 18, 2026, the Fund's name will be The NXG Cushing® Energy Infrastructure Fund.There will be no change to the Fund's New York Stock Exchange ticker symbol in connection with the name change. The CUSIP for the Fund's common shares will remain 231631300 following the name change.Principal Investment Strategies of the FundThe Fund will continue to pursue its investment objective to obtain a high after-tax total retu

Scholar Rock (NASDAQ:SRRK, the "Company")) today announced that the Company granted inducement equity awards covering an aggregate of 61,020 shares of its common stock to seven newly hired employees, consisting of inducement stock options to purchase an aggregate of 17,461 shares of common stock and inducement restricted stock units, covering an aggregate of 43,559 shares of its common stock. The awards are subject to all terms and conditions and other provisions set forth in the Company’s 2022 Inducement Equity Plan (the "Plan") and the award agreements thereunder. The Plan, initially adopted by the Company’s board of directors on June 16, 2022, and as amended from time to time, is use

HAUPPAUGE, N.Y., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Dime Commercial Bancshares, Inc. (NYSE:DCOM) (the "Company") today announced that the Company expects to release its earnings for the quarter ended September 30, 2026, before the open of the U.S. equity markets on Tuesday, October 20, 2026. The Company will conduct a conference call at 8:30 a.m. (ET) on Tuesday, October 20, 2026, during which President and Chief Executive Officer ("CEO"), Stuart Lubow, will discuss the Company’s third quarter financial performance. There will be a question-and-answer period after the CEO remarks. Participants may access the conference call via webcast using this link: Webcast Link Here. To participate via

KINGSTON, N.Y., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kingstone Companies, Inc. (NASDAQ:KINS) ("Kingstone" or the "Company"), a regional property and casualty insurance holding company, today announced that it will issue financial results for the third quarter ended September 30, 2026, after the market closes on Thursday, November 5, 2026. Management will host a conference call to discuss the Company’s business operations and financial results at 8:30 a.m. ET on Friday, November 6, 2026. Participants are asked to dial in approximately 10 minutes before the conference call is scheduled to begin using the following numbers: U.S. toll-free: 1-877-407-2991International: 1-201-389-0925 A live we

WALTHAM, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on October 15, 2026 (the "Grant Date"), the Compensation Committee of the Company’s Board of Directors granted an aggregate of 74,900 restricted stock units of the Company’s common stock ("RSUs") to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listin

"The Trillion Dollar AI Bottleneck"- Exploring the Technologies Powering the Next Wave of Artificial Intelligence Kopin Corporation (NASDAQ:KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, invites investors, technology professionals, industry observers, and AI enthusiasts to virtually join a YouTube "Ask Me Anything" (AMA) event titled "The Trillion Dollar AI Bottleneck" on October 20, 2026, at 11:00 a.m. EDT, streamed live from Nasdaq MarketSite. Livestream Access: Live From NYC: The Trillion Dollar AI Bottleneck Participants are encouraged to virtually jo

Rayonier Inc. (NYSE:RYN) announced today that the Company’s board of directors has declared a fourth quarter cash dividend of $0.26 per common share. The dividend is payable on December 31, 2026, to shareholders of record on December 17, 2026. The Company also announced today that the Company’s board of directors, in its capacity as the board of directors of the general partner of Rayonier, L.P., has declared a fourth quarter cash distribution of $0.26 per operating partnership unit. The cash distribution is payable on December 31, 2026, to holders of record on December 17, 2026. About Rayonier Rayonier is a land resources real estate investment trust (REIT) with a portfolio comprisin

NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Omnicom (NYSE:OMC) will publish its third quarter 2026 results on Thursday, October 22, 2026 after the New York Stock Exchange close of trading. The company will also host a conference call to review such financial results on Thursday, October 22, 2026, starting at 4:30 p.m. Eastern Time. A live webcast of the call will be available at Omnicom's investor relations website, investor.omc.com, along with the related earnings press release and slide presentation. A webcast replay will be made available after the call concludes. About OmnicomOmnicom (NYSE:OMC) is the world's leading marketing and sales company. Powered by Omni, its proprietary data and iden

PITTSBURGH, Oct. 16, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults. RYZUMVI is currently approved in the United States for the treatment of pharmacologically-induced mydriasis and is the only commercially available FDA-approved product for that use. This approval expands the product's indications to include presbyopia.Viatris is exploring the potential for a partner in the United States to commercialize RYZUMVI for the treatment of presbyopia.About Opus Genetics and Viatris CollaborationOpus G

8x8, Inc. (NASDAQ:EGHT), a leading global business communications platform provider, has scheduled the release of financial results for the second quarter of fiscal 2027 following the close of market on Wednesday, November 4, 2026. The company will host a conference call on the same day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results. Date:     November 4, 2026 Time:     2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Dial In:     Register to participate in the live call. Upon registering, you will receive dial-in numbers and a unique PIN to join the call. You will also receive an email confi

ASA Gold and Precious Metals Limited (the "Company") (NYSE:ASA) declared a distribution of $0.05 per common share of the Company. The distribution is payable on November 12, 2026 to shareholders of record as of the close of business on November 5, 2026.You should not draw any conclusions about the Company’s investment performance based on the amount of the distribution declared. The frequency and amount of future distributions, if any, are subject to change. Investors are encouraged to visit the Company’s website for additional information, including historical and current share prices, news releases, financial statements, tax and supplemental information. The site may be found at www.asaltd

CAMBRIDGE, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (NASDAQ:KRRO), a clinical-stage biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced the grant of non-statutory stock options to two newly hired employees. Korro granted the new employees nonstatutory stock options to purchase 4,000 shares of Korro’s common stock, in the aggregate, at an exercise price of $8.88 per share, the closing price per share of Korro's common stock as reported by Nasdaq on the grant effective date, October 14, 2026. The options each have a te

EMERYVILLE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on October 13, 2026, the compensation committee of the Company’s board of directors granted 13 new non-executive employees options to purchase an aggregate of 260,000 shares of the Company’s common stock and 157,600 Restricted Stock Units (RSUs). Each stock option has an exercise price per share equal to $12.36, which was the closing trading price on October 13, 2026

PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today provided a brief business update and furnished certain preliminary unaudited financial data for the third quarter ended September 30, 2026. The preliminary figures are estimates based on currently available information, are preliminary and unaudited, and are subject to change upon completion of the Company’s financial close process, final adjustments, management review and other internal procedures, and review by its independent auditors. The Company’s final reported unaudited financial results for the third quarter of

DURANGO, Colo., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) (the "Company" or "RMCF"), America’s Chocolatier® since 1981, will host a conference call on Monday, October 19, 2026 at 5:00 p.m Eastern time to discuss its fiscal second quarter 2027 results. The Company’s results will be reported in a press release prior to the call. The RMCF management team will host the conference call. There will be no question-and-answer session. The conference call details are as follows: Date: Monday, October 19, 2026Time: 5:00 p.m. Eastern timeDial-in registration link: hereLive webcast registration link: here Please dial into the conference call 5-10 minutes

MONTREAL, Oct. 16, 2026 (GLOBE NEWSWIRE) -- TFI International Inc. (NYSE and TSX:TFII), a North American leader in the transportation and logistics industry, today announced that its webcast discussing financial results for the third quarter 2026 will be held on Friday, October 30, 2026 at 8:30 AM Eastern Time. The Company still expects to release earnings results Thursday, October 29, 2026, after market close. Webcast Details: Date: Friday, October 30, 2026Time: 8:30 AM Eastern TimeLive webcast & replay: Presentations & Reports within the Investors section of the Company website. Alternatively for the live webcast visit webcast. ABOUT TFI INTERNATIONAL TFI International Inc. is a Nort

DUBAI, UAE, October 16, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO) (the "Company"), a UAE-based, U.S.-listed company, today announced that, subject to shareholder approval, the Company will implement a 1 for 25 reverse stock split of all classes of the Company's ordinary shares, including the Class A ordinary shares and the publicly traded Class B ordinary shares, effective at 9:30 am, U.S. Eastern time, on November 6, 2026. Before the reverse stock split, there were 13,817,501 Class A ordinary shares and 222,116,290 Class B ordinary shares issued and outstanding. After the reverse stock split, there will be 552,701 Class A ordinary shares and 8,884,684 Class B ordinary shares issued an